Research Projects

Continually improving patient care through research studies is a goal of the INTEGRIS Heart Hospital (IHH). The wide array of research studies taking place at the INTEGRIS Heart Hospital demonstrates our commitment.

The table below denotes the enrolling research studies for IHH. Please contact the Coordinator listed for detailed inclusion / exclusion criteria for each study:

Study Description Coordinator Name
Phone Number
E-mail
A device study intended for the non-surgical closure of patent foramen ovale (PFO) in those patients who have had recurrent cryptogenic strokes despite being on medication to prevent strokes. George Chrysant, M.D.
405-947-3341
A study of investigational drug in patients with acute myocardial infarction (MI)(heart attack) undergoing primary percutaneous coronary intervention (PCI). Donna Kimball, RN
405-949-3178
A randomized dose investigational drug study for patients with non-ST-segment elevation acute coronary syndromes (ACS). Bethany Jill Fife, RN
405-951-8607
bethany.fife@integrisok.com
A randomized dose investigational drug study for patients with non-ST-segment elevation acute coronary syndromes (ACS). Bethany Jill Fife, RN
405-951-8607
bethany.fife@integrisok.com
A drug study for patients with non-ST segment elevation acute coronary syndrome (ACS). Donna Kimball, RN
405-949-3178 
Research study to develop a technique of assessing coronary artery narrowing using an electron beam computed Tomography (EBCT). This technique is a promising, non-invasive way of evaluating coronary artery disease (CAD). George Chrysant, M.D.
405-947-3341
A long-term drug study in subjects hospitalized with worsening congestive heart failure. Pentrina West, RN
405-951-2894
pentrina.west@integrisok.com
Venous thromboembolism (VTE) is a major public health concern in both surgical and medically ill patients. This research study will assess the superiority of extended VTE prophylaxis in acutely ill medical patients with prolonged immobilization. Angela Dawn Vines, RN
405-949-4020
dawn.vines@integrisok.com
A research study to evaluate the efficacy and safety of investigational drug administered as serial infusions to heart failure (HF) patients in the outpatient setting. Angela Dawn Vines, N
405-949-4020
dawn.vines@integrisok.com
A clinical research study to evaluate the effect of an investigation drug for the treatment of atrial fibrillation (heart rhythm disturbance). Angela Dawn Vines, RN
405-949-4020
dawn.vines@integrisok.com
A research study to evaluate the effectiveness of investigational drugs for reducing low-density lipoprotein cholesterol (LDL-C) levels in patients with acute coronary syndromes (ACS). Angela Dawn Vines, RN
405-949-4020
dawn.vines@integrisok.com
A clinical trial to evaluate the effectiveness of investigational drugs in patients with non-ST segment elevation acute coronary syndromes (ACS). Angela Dawn Vines, RN
405-949-4020
dawn.vines@integrisok.com
A clinical study to assess the effectiveness and safety of IV administered investigational drugs in reducing all-cause mortality and myocardial infarctions (MI)(heart attack) in patients undergoing coronary artery by-pass graft surgery with cardiopulmonary bypass. Bethany Jill Fife, RN
405-951-8607
bethany.fife@integrisok.com
A research study comparing investigational drugs in acute coronary syndrome (ACS) subjects who are to undergo percutaneous coronary intervention (PCI). Pentrina West, RN
405-951-2894
pentrina.west@integrisok.com
A clinical study to evaluate the effectiveness of a novel new anticoagulant (blood thinner) and an established anticoagulant, infractionated heparin, when given with other medication regimens to patients undergoing percutaneous coronary intervention (PCI). This study is for patients with coronary artery disease (CAD). Bethany Jill Fife, RN
405-951-8607
bethany.fife@integrisok.com
A clinical study for patients needing a dual-chamber pacemaker to adequately treat their abnormal heartbeat. Along with the pacemaker investigational silicone leads will be implanted to evaluate the safety and effectiveness of these leads. Donna Kimball, RN
405-949-3178 

 



© 2017 INTEGRIS Health Pencil
Oklahoma's largest hospital network
3300 N.W. Expressway
Oklahoma City, OK 73112 Phone: (405) 951-2277
Back to Top